Johanna Mercier

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
6 years
Director since
2023

6 years of board service in total across 2 boards, counting each seat separately. Longest: Neurocrine Biosciences Inc., 3 years.

3 years · Since 2023
2 years · Since 2024

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Oct 15, 2026 Gilead Sciences Inc. Open-market sale −3,000 $156.22 $468,660
Sep 15, 2026 Gilead Sciences Inc. Open-market sale −1,600 $143.69 $229,904
Sep 15, 2026 Gilead Sciences Inc. Open-market sale −800 $144.46 $115,568
Sep 15, 2026 Gilead Sciences Inc. Open-market sale −600 $145.29 $87,174
Sep 10, 2026 Gilead Sciences Inc. Option exercise +2,797 — —
Sep 10, 2026 Gilead Sciences Inc. Shares withheld for tax −1,347 $144.81 $195,059
Aug 17, 2026 Gilead Sciences Inc. Option exercise +23,110 $66.64 $1,540,050
Aug 17, 2026 Gilead Sciences Inc. Option exercise +1,890 $72.34 $136,723
Aug 17, 2026 Gilead Sciences Inc. Open-market sale −16,530 $137.37 $2,270,726
Aug 17, 2026 Gilead Sciences Inc. Open-market sale −11,470 $138.04 $1,583,319
Jul 15, 2026 Gilead Sciences Inc. Open-market sale −3,000 $129.92 $389,760
Jun 15, 2026 Gilead Sciences Inc. Open-market sale −1,480 $123.42 $182,662
Jun 15, 2026 Gilead Sciences Inc. Open-market sale −1,070 $124.00 $132,680
Jun 15, 2026 Gilead Sciences Inc. Open-market sale −450 $125.40 $56,430
Jun 10, 2026 Gilead Sciences Inc. Option exercise +2,796 — —

Questions about Johanna Mercier

What boards is Johanna Mercier on?

Johanna Mercier sits on the boards of Arcus Biosciences Inc. and Neurocrine Biosciences Inc.

How long has Johanna Mercier served on boards?

Our records show at least 6 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.